Tyler advises clients on a range of corporate matters including formation, venture capital financings, mergers and acquisitions, private equity transactions, securities offerings, SEC reporting obligations and corporate governance.
Autolus Announces Strategic Collaboration With BioNTech, $350 Million Underwritten Offering
February 8, 2024
Cooley advised Autolus – a clinical-stage biopharmaceutical company developing next-generation programmed T-cell therapies – on its strategic collaboration with BioNTech, an immunotherapy company pioneering novel therapies for cancer and other serious diseases, to advance both companies’ autologous CAR-T programs toward commercialization, as well as a $350 million underwritten offering.
